2023 ABMGG CertLink Education Credit
Tracking # 20-1105660
Free
There are no ratings for this course
Learn moreCourse overview
Longitudinal assessment is a method that has been shown to enhance information retention and facilitate new learning. The diplomate completes shorter, more frequent assessments with spaced repetition (seeing similar questions repeated periodically). It can be likened to quizzing, identifying your knowledge gaps and learning new material, then re-quizzing at a later time to see if you have retained or learned the information. Research on this method has shown that the act of quizzing and re-quizzing over time improves learning and memory retention better than other study methods, such as reading a text or studying flashcards. ABMGG CertLink meets ACCME requirements for continuing medical education with assessment.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
Accredited Continuing Education Financial Disclosure
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.
ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Name
Program Committee Member
Financial Disclosure Relationship/Company
Carlos Bacino, MD, FACMG
¿
Nothing to disclose
Miriam Blitzer, PhD, FACMG
¿
Nothing to disclose
Nicole Hoppman, PhD, FACMG
¿
Nothing to disclose
Peter J. Hulick, MD, FACMG
¿
Reported disclosures and none are relevant to the content of this course.
Collen Jackson-Cook, PhD, FACMG
¿
Nothing to disclose
Marzia Pasquali, PhD, FACMG
¿
Consultant: Horizon Therapeutics, Recordati Rare Diseases
Katie Rudd, PhD, FACMG
¿
Employee: LabCorp America
J. Daniel Sharer, PhD, FACMG
¿
Consultant: PTC Therapeutics, Inc.
Darrel Waggoner, MD, FACMG
¿
Nothing to disclose
William Wilson, MD, FACMG
¿
Nothing to disclose